KalVista Pharmaceuticals Announces Appointment of Brian J.G. Pereira, M.D. as Board Chairman
yahoo.com
news
2022-10-17 10:45:00

â€“ Current Board Chairman Martin Edwards, M.D. to Retire in Planned Transition -

CAMBRIDGE, Mass. & SALISBURY, England, October 17, 2022--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that the Board of Directors has appointed current member Brian J.G. Pereira, M.D., as Chairman, effective immediately. In conjunction, current Chairman Martin Edwards, M.
